From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

from News-Medical.net

The U.S. Food and Drug Administration recently expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063